USPTO serial 87021064
THERA NEUROPHARMA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHADAB, SETH WILLIG
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with THERA NEUROPHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sherry Flax
SHERRY FLAX SAUL EWING LLP500 E. PRATT ST.SUITE 900BALTIMORE, MD 21202Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for the treatment of central nervous system and neurological conditions and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous systems and neurological conditions and disorders; Pharmaceutical preparations for central nervous system and neurological conditions and disorders; Pharmaceutical preparations acting on the central nervous system | ACTIVE | — |
| 042 | Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research and development and consultation related thereto in the field of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Research in the field of central nervous system and neurological conditions and disorders; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Laboratory research in the field of central nervous system and neurological conditions and disorders; Medical laboratory services; Scientific research for medical purposes in the field of pharmaceuticals for the diagnosis and treatment of central nervous systems and neurological conditions and disorders; Scientific research in the field of pharmaceuticals; Technical consulting in the field of pharmaceutical studies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Thera Neuropharma, Inc.
- Other trademarks owned by Thera Neuropharma, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named THERA NEUROPHARMA
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 9, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 16, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 14, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 14, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 8, 2017 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Dec 7, 2017 | TPEX | SOU EXTENSION RECEIVED WITH TEAS PETITION | — |
| Dec 7, 2017 | PETG | PETITION TO REVIVE-GRANTED | — |
| Dec 7, 2017 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 6, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 6, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 11, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 11, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 22, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 2, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 16, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 15, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 15, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 24, 2016 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 24, 2016 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 24, 2016 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 17, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 5, 2016 | NWAP | NEW APPLICATION ENTERED | — |